BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld
Home
» Other news to note for Feb. 9, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Feb. 9, 2021
Feb. 11, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adnab, Aerami, Algernon, Alterity, Antibe, Apollomics, Applied Biomath, Arch, Area, Azurrx, Basilea, Bostongene, Camargo, Cellular Biomedicine, Chance, Charles River, Compass Pathways, Edison, Eikonizo, Eloxx, Evotec, Freeline, Hengrui, Herantis, Homology, Hoth, Jemincare, Jubilant, Lannett, Lassen, Merck & Co., Nanoform, Nuance, Otsuka, Pfizer, PPD, Respirerx, Revitope, Sigilon, Sorrento, Stemedix, Synaptogenix, Taysha, Tmunity, Tryp, Yingli.
BioWorld
Briefs
Other news to note
Coronavirus